StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.21−0.08 (-1.27%)

Close on Nov 17, 2026Market cap $279.58MP/E –Yield –

Agenus operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Agenus's operating income for the twelve months ending Jun 30, 2026 was $36.20M. For fiscal 2025 it was -$20.17M. The highest annual figure on record is $25.75M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.17M–
FY2024Dec 31, 2024-$120.48M–
FY2023Dec 31, 2023-$159.55M–
FY2022Dec 31, 2022-$179.43M-796.9%
FY2021Dec 31, 2021$25.75M–
FY2020Dec 31, 2020-$117.24M–
FY2019Dec 31, 2019-$70.14M–
FY2018Dec 31, 2018-$123.82M–
FY2017Dec 31, 2017-$103.80M–
FY2016Dec 31, 2016-$107.48M–
FY2015Dec 31, 2015-$80.70M–
FY2014Dec 31, 2014-$43.32M–
FY2013Dec 31, 2013-$24.98M–
FY2012Dec 31, 2012-$6.74M–
FY2011Dec 31, 2011-$19.09M–
FY2010Dec 31, 2010-$21.75M–
FY2009Dec 31, 2009-$27.68M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.29M–
Q1 FY2026Mar 31, 2026$15.05M–
Q4 FY2025Dec 31, 2025$14.40M–
Q3 FY2025Sep 30, 2025-$4.55M–
Q2 FY2025Jun 30, 2025-$16.71M–
Q1 FY2025Mar 31, 2025-$13.31M–
Q4 FY2024Dec 31, 2024-$25.90M–
Q3 FY2024Sep 30, 2024-$31.50M–
Q2 FY2024Jun 30, 2024-$30.19M–
Q1 FY2024Mar 31, 2024-$32.88M–
Q4 FY2023Dec 31, 2023-$4.20M–
Q3 FY2023Sep 30, 2023-$46.34M–
Q2 FY2023Jun 30, 2023-$54.67M–
Q1 FY2023Mar 31, 2023-$54.34M–
Q4 FY2022Dec 31, 2022-$57.76M–
Q3 FY2022Sep 30, 2022-$41.65M-122.2%
Q2 FY2022Jun 30, 2022-$44.57M–
Q1 FY2022Mar 31, 2022-$35.46M–
Q4 FY2021Dec 31, 2021-$54.03M–
Q3 FY2021Sep 30, 2021$187.54M–
Q2 FY2021Jun 30, 2021-$66.40M–
Q1 FY2021Mar 31, 2021-$41.37M–
Q4 FY2020Dec 31, 2020-$21.71M–
Q3 FY2020Sep 30, 2020-$34.79M–
Q2 FY2020Jun 30, 2020-$33.27M–
Q1 FY2020Mar 31, 2020-$27.46M-204.8%
Q4 FY2019Dec 31, 2019-$19.28M–
Q3 FY2019Sep 30, 2019-$35.92M–
Q2 FY2019Jun 30, 2019-$41.15M–
Q1 FY2019Mar 31, 2019$26.21M–
Q4 FY2018Dec 31, 2018-$39.43M–
Q3 FY2018Sep 30, 2018-$26.08M–
Q2 FY2018Jun 30, 2018-$16.57M–
Q1 FY2018Mar 31, 2018-$41.75M–
Q4 FY2017Dec 31, 2017-$29.99M–
Q3 FY2017Sep 30, 2017-$31.66M–
Q2 FY2017Jun 30, 2017-$28.89M–
Q1 FY2017Mar 31, 2017-$13.26M–
Q4 FY2016Dec 31, 2016-$19.68M–
Q3 FY2016Sep 30, 2016-$36.22M–

More Agenus figures

See a number that looks wrong?